Asset Manager

Updated:

Transhuman Capital

Investing in hard science to solve humanity's big problems | We invest in therapeutics, medical devices, and other technologies that have the potential to...

Transhuman Capital logo

Transhuman Capital

Investing in hard science to solve humanity's big problems | We invest in therapeutics, medical devices, and other technologies that have the potential to fundamentally improve the human condition. Our vision is a society where everyone can live a long, healthy, daring and meaningful life.

General information

Firm type

Generalist

Year founded

2014

Location

Region

North America

Country

United States

City

Ann Arbor

Corporate office

Ann Arbor, MI, United States

Frequently asked questions

Who runs investment decisions at Transhuman Capital?

No named principals—including a CEO, CIO, or managing partner—appear in public records for Transhuman Capital. The firm does not maintain a discernible LinkedIn presence, and its website does not list any leadership biographies or investment committee members. Allocators should assume that investment decision-making authority is not externally documented.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Ann Arbor Generalist profiles